Kim, Y. K., Hwang, J. G., & Park, M. K. (2021). No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects. Drug Des Devel Ther.
Čikaški stil citiranjaKim, Yu Kyong, Jun Gi Hwang, i Min Kyu Park. "No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects." Drug Des Devel Ther 2021.
MLA način citiranjaKim, Yu Kyong, Jun Gi Hwang, i Min Kyu Park. "No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects." Drug Des Devel Ther 2021.